Original Research
Accepted on 28 Feb 2025
Ribosomal protein L9 is a potential therapeutic target for B-ALL through the activation of the p53 signaling pathway
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 28 Feb 2025
in Cancer Immunity and Immunotherapy
Brief Research Report
Accepted on 28 Feb 2025
in Nutritional Immunology
Original Research
Accepted on 28 Feb 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 28 Feb 2025
in Inflammation
Original Research
Accepted on 28 Feb 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 28 Feb 2025
in Inflammation
Review
Accepted on 28 Feb 2025
in Viral Immunology
Hypothesis and Theory
Accepted on 28 Feb 2025
in Immunological Tolerance and Regulation
Review
Accepted on 28 Feb 2025
in Vaccines and Molecular Therapeutics
Original Research
Accepted on 28 Feb 2025
in Microbial Immunology
Review
Accepted on 28 Feb 2025
in Cytokines and Soluble Mediators in Immunity
Case Report
Accepted on 28 Feb 2025
in Cancer Immunity and Immunotherapy
Systematic Review
Accepted on 28 Feb 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 28 Feb 2025
in Parasite Immunology
Original Research
Published on 28 Feb 2025
in Inflammation
Review
Published on 28 Feb 2025
in Molecular Innate Immunity